Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)

v3.7.0.1
Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Mar. 31, 2017
Mar. 31, 2016
Net sales $ 144,037 $ 130,973 $ 406,425 $ 364,261
Cost of sales 49,854 40,984 142,691 117,294
Gross margin 94,183 89,989 263,734 246,967
Operating expenses:        
Selling, general and administrative 48,107 35,217 150,025 102,842
Research and development 13,771 11,245 39,817 33,544
Total operating expenses 61,878 46,462 189,842 136,386
Operating income 32,305 43,527 73,892 110,581
Other income (expense) (2,275) (1,037) (6,196) (870)
Earnings before income taxes 30,030 42,490 67,696 109,711
Income taxes 8,641 12,199 23,712 30,861
Net earnings 21,389 30,291 43,984 78,850
Other comprehensive income:        
Foreign currency translation adjustments 2,400 7,128 (10,899) (13,262)
Unrealized gain (loss) on available-for-sale investments, net of tax of $293, $3,611, $(1,767), and $3,917, respectively (475) (32,081) 16,010 (32,605)
Other comprehensive (loss) income 1,925 (24,953) 5,111 (45,867)
Comprehensive income (loss) $ 23,314 $ 5,338 $ 49,095 $ 32,983
Earnings per share:        
Basic (in dollars per share) $ 0.57 $ 0.81 $ 1.18 $ 2.12
Diluted (in dollars per share) 0.57 0.81 1.17 2.11
Cash dividends per common share: (in dollars per share) $ 0.32 $ 0.32 $ 0.96 $ 0.96
Weighted average common shares outstanding:        
Basic (in shares) 37,320 37,196 37,303 37,185
Diluted (in shares) 37,494 37,299 37,486 37,307